The contribution of the short wavelength ultraviolet (UV) component of sunlight to the aetiology of skin cancer has been widely acknowledged, although its direct contribution to tumour initiation or progression is still poorly understood. The loss of normal cell cycle controls, particularly checkpoint controls, are a common feature of cancer. UV radiation causes both G1 and G2 phase checkpoint arrest in vitro cultured cells. In this study we have investigated the cell cycle responses to suberythemal doses of UV on skin. We have utilized short-term whole organ skin cultures, and multi parameter immunohistochemical and biochemical analysis to demonstrate that basal and suprabasal layer melanocytes and keratinocytes undergo a G2 phase cell cycle arrest for up to 48 h following irradiation. The arrest is associated with increased p16 expression but no apparent p53 involvement. This type of organ culture provides a very useful model system, combining the ease of in vitro manipulation with the ability to perform detailed molecular analysis in a normal tissue environment. Oncogene (2001) 20, 6103 ± 6110.
Introduction
The role of ultraviolet radiation (UVR) as one aetiological factor in the development of skin cancer, including melanoma, is well established (Elder, 1989) , with UVR acting as both an initiator and promoter in the course of multi-step carcinogenesis (Wikonkal and Brash, 1999) . UVR has a range of eects on epidermally-derived cells in vitro and in vivo. It directly increases the pigment production and the dendricity of melanocytes (Friedmann and Gilchrest, 1987) , and may also act as an independent mitogen for these cells (Libow et al., 1988) . Studies have also demonstrated that UVR induces the production of keratinocytederived factors that regulate keratinocyte and melanocyte growth in an autocrine/paracrine manner (Ley and Ellem, 1992; Im et al., 1998; Thody and Graham, 1998) . Exposure to simulated solar radiation at doses equivalent to a minimal erythemal dose (1MED), can produce DNA damage and stimulate unscheduled DNA synthesis (i.e. excision repair mechanisms) in basal and suprabasal layer cells in the skin (Freeman et al., 1987; Honigsmann et al., 1987) . Studies using cultured cells have reported both G1 and G2 phase cell cycle arrests as responses to DNA damage induced by UVR. The G1 arrest appears to be through a p53-dependent mechanism (Lu and Lane, 1993; Herzinger et al., 1995) , whereas the G2 arrest is independent of p53, and involves a block in the cdc25-dependent activation of the mitotic cyclin dependent kinase (CDK) complexes (Herzinger et al., 1995; Gabrielli et al., 1997b) .
A number of human genetic mutations are associated with melanoma. Of these, p16/CDKN2A, which is functionally inactivated in a high proportion of melanoma cell lines and in 10 ± 30% of tumours (Castellano and Parmiani, 1999) , is a direct eector of cell cycle progression. Mutations of p16/CDKN2A have also been identi®ed in non-melanoma skin cancers (Sou®r et al., 1999) . Ectopic expression of p16 in dierent tumour lines has been shown to inhibit cell growth via a Rb-dependent G1 phase arrest, due to the ability of p16 to speci®cally bind and inhibit CDK4 and CDK6 (Ruas and Peters, 1998) . The physiological roles for p16 are still poorly de®ned, but it has been implicated in replicative senescence (Haddad et al., 1999; Dickson et al., 2000) , and a G1 phase checkpoint response to DNA damage (Shapiro et al., 1998) . We have previously reported increased p16 levels in response to suberythemal doses of short wavelength UVR in cultures of melanocyte and keratinocytederived cells (Wang et al., 1996; Milligan et al., 1998) , which correlates with a G2 phase delay. Loss of the UV-induced G2 checkpoint arrest corresponded to an increase in the proportion of cells with fractured nuclei, a result of cells undergoing aberrant mitosis (Milligan et al., 1998) , demonstrating the importance of this checkpoint for the maintenance of genomic integrity. We have also reported a strong increase in p16 expression in response to suberythemal doses of UVR in human skin (Pavey et al., 1999) , suggesting that the elevated p16 levels may be involved in the normal cellular responses to sunlight exposure, possibly in a cell cycle response.
Much work on UV responses, particularly cell cycle responses, has used cultured cell lines, many of which are non-epidermal in origin, e.g. ®broblasts. The anatomical organization of skin and penetration characteristics of dierent wavelength UVR mean that conclusions from in vitro studies may not be directly transferable to human skin. This is in part because the mutagenic potential of a particular wavelength in vivo will be a function of both the dose received by the stem cells in the basal layer and the eectiveness of the radiation in inducing DNA damage (Campbell et al., 1993; Pavey et al., 1999) . Studies examining the eects of UVR on primary cultures of melanocytes and keratinocytes, which are physiological targets for the mutagenic UVB component of solar radiation, have overlooked the potential paracrine eects on the biological and physiological responses of these cells. In this study we have utilized a short-term whole skin organ culture model to examine whether the G2 phase cell cycle arrest we have observed after low dose UVR in cultured cell lines was also a response of basal layer cells in the skin. We have used multi-parameter analyses of a number of markers of cell cycle stage, and biochemical analysis to demonstrate a G2 phase cell cycle arrest in the basal and suprabasal layer keratinocytes and melanocytes 24 ± 48 h after exposure to suberythemal doses of UVB. The G2 arrest is associated with elevated levels of p16, but surprisingly little or no increase in p53 or its downstream eectors of cell cycle arrest, p21/WAF1 or GADD45, were detected. The cell cycle responses observed are dierent from that observed with in vitro cultured primary melanocytes and keratinocytes, suggesting that the tissue environment in¯uences cell cycle responses of the basal layer cells.
Results
The expression and localization of a number of markers of cell cycle stage were examined by immunohistochemical and biochemical analysis of unirradiated control skin and after irradiation with suberythemal doses of UVB (250 ± 875 Jm 72 ). Cyclin B1 was examined as marker of G2 phase. Its expression increases from late S phase, and in UVR treated, G2 arrested cells, it is expressed at normal G2 phase levels and complexed with the Tyr15 phosphorylated, inactive form of cdc2 (Gabrielli et al., 1997b) . When the levels of cyclin B1 expressed in skin were examined, it was found to be low to undetectable in unirradiated, control skin, but increased in both number of positive staining cells and intensity of staining at 24 h after UVR treatment (Figure 1a,b) . Cyclin B1 staining in the irradiated skin was both nuclear and cytoplasmic, and con®ned to basal and suprabasal layer melanocytes and keratinocytes ( Figure  1b) . The proportion of epidermal cells immunolabelled with cyclin B1 in skin samples increased from control levels at 8 h to a peak at 24 h, which was maintained at 48 h and decreased by 72 h following UV irradiation (Figure 2) . Immunoblotting of tissue extracts of similar control and UV irradiated samples harvested at 24 h after irradiation revealed strong increase in both cyclin B1 and cdc2 levels, and the level of phosphotyrosine 15 form of cdc2 (PY15) in irradiated compared with control samples (Figure 3a) . PY15 was also detected in basal and suprabasal layer cells at 24 h following irradiation by immunohistochemistry and localized to both cytoplasm and nucleus, similar to the localization of cyclin B1 (data not shown). Although there is an absolute requirement for cyclin association with cdc2 to permit Tyr15 phosphorylation, the direct association of the increased cyclin B1 and PY15 staining detected by immunohistochemistry and immunoblotting was con®rmed by analysis of cyclin B1 immunoprecipitates from similar tissue extracts. This revealed a strong accumulation of the inactive phosphotyrosine 15 form of cdc2 associated with cyclin B1 in UV irradiated samples over controls similar to that detected by immunoblotting of the tissue extracts (Figure 3a,b) .
The accumulation of inactive phosphotyrosine 15 cdc2/cyclin B1 in the basal layer cells of irradiated skin was suggestive of a G2 phase cell cycle arrest in these cells. The delay of up to 16 h before signi®cant accumulation of cyclin B1 was observed would predict that these cells had progressed through S phase during the ®rst 24 h after irradiation, and if arrested, would not enter S phase during the next 24 h. To examine this, skin samples were incubated with BrdU from 0 ± 24 h or 24 ± 48 h following UV irradiation. Parallel BrdU labelling experiments of unirradiated controls were also performed. Few cells in the control skin were BrdU positive, and there was a 4sevenfold increase in irradiated skin incubated with BrdU during the initial 24 h after irradiation (Figures 1c, d and 4) . Skin samples labelled with BrdU from 24 ± 48 h after irradiation revealed a fourfold decrease in the number of BrdU positive cells compared to the 0 ± 24 h BrdU labelling experiments (Figure 4 ), suggestive of a decrease in S phase cells from 24 ± 48 h after irradiation. There were no signi®cant dierences in control levels of incorporation during the two time periods. The intensity and uniformity of BrdU staining throughout the nucleus indicated that cells had undergone S phase rather than DNA repair, which is marked by intense patches of nucleotide incorporation (Lu and Lane, 1993) .
As a separate measure of S phase, immunohistochemical staining for PCNA, a co-factor for DNA polymerase delta, was performed. In control unirradiated samples, PCNA staining was uniform throughout the basal and suprabasal layer cells and exclusively nuclear (Figure 1e ). By 24 h after UV irradiation, there was a dramatic change in the localization of PCNA, with it relocating from the nucleus to the cytoplasm at this time ( Figure 1f ). Strong cytoplasmic staining was detected at 16 h following UV irradiation, and by 24 h 97% of cells displayed strong cytoplasmic staining ( Figure 5 ). There was a corresponding loss of nuclear PCNA, with only 10% of cells displaying weak nuclear staining. By 48 h, 26% of cells had nuclear PCNA staining, and by 72 h the majority of PCNA staining was con®ned to the nucleus, with the intensity of the remaining cytoplasmic staining observed reduced compared to 24 h. Immunoblotting of tissue extracts revealed no changes in PCNA levels following irradiation (Figure 2a) .
These data were suggestive of either a G2 phase arrest or a wave of cells passing through G2/M at 24 h after irradiation due to quasi synchronous stimulation of the basal layer cells provided by UVR. However, the persistence of the elevated cyclin B1 staining at 48 h and relative reduction in S phase cells from 24 ± 48 h as compared to the initial 24 h after irradiation, as measured by both the BrdU incorporation and loss of nuclear PCNA, indicated that it was likely to be a G2 phase arrest. Further evidence to support this was found with immunoblotting of extracts of skin harvested at 48 h after irradiation. Elevated levels of cyclin B1 and corresponding increased PY15 were found to persist in the irradiated compared to control skin ( Figure 6 ). Caeine is a potent inhibitor of the ATM-related ATR (Sarkaria et al., 1999) which is implicated in the UV-induced G2 arrest (Cliby et al., 1998) , and addition of caeine abrogates the UVinduced G2 phase arrest in HeLa cells . When caeine was added to irradiated skin samples at 24 h after irradiation then harvested at 48 h, there was a loss of the cyclin B1 accumulation and PY15 band detected in the 48 h irradiated samples indicative of exit from the G2 phase arrest (Figure 6 ).
We have previously demonstrated that p16 is induced in human skin following low dose UV radiation (Pavey et al., 1999) (Figure 7a,b) . By using Figure 2 Skin samples were harvested at the indicated times after irradiation and immunostained for cyclin B1. The proportion of cyclin B1 positive cells were quanti®ed as described in Materials and methods double immunohistochemical staining techniques, cyclin B1 was found to co-localize with p16 in 480% of p16 positive cells (Figure 7c,d ). Strong p16 staining was also found in BrdU positive cells from the initial 24 h labelling experiments (Figures 6e,f) , with 67% of cells staining for p16 also labelled with BrdU. p16 staining also corresponded to the relocation of PCNA from the nucleus to the cytoplasm in irradiated cells with 480% of p16 positive cells displaying predominantly cytoplasmic staining for PCNA at 24 h after irradiation.
The level of p53 was also examined by immunoblotting of the tissue extracts. No changes in p53 expression were detected (Figure 3a) , con®rming our earlier immunohistochemical observations (Pavey et al., 1999) . We have also examined the levels of transcriptional targets of p53, p21/WAF1 and GADD45, to assess whether p53 was transcriptionally active after UVR exposure. Control unirradiated skin contained detectable levels of p21/WAF1 within the suprabasal, spinous and granular cell layers (Figure 7g) , with approximately 10% of epidermal cells expressing low levels of p21/WAF1 (Figure 8 ). The proportion of cells expressing p21/WAF1 increased twofold by 16 h after irradiation, then dropped dramatically by 24 h to approximately 2%, and remained at these levels through to 72 h post-UV (Figures 7h and 8) . The increase in p21/WAF1 staining was restricted to the spinous and granular cell layers. Only very low levels of GADD45 were detected and these increased 5twofold following UV exposure (Figure 3) . The small changes in GADD45 levels detected by immunoblotting of the tissue extracts were not associated with any detectable change in GADD45 staining in the basal layer compartment, where only weak staining was observed. GADD45 has been demonstrated to act as direct binding inhibitor of the cyclin B/cdc2 complex (Zhan et al., 1999) . However, we were unable to detect any GADD45 associated with cyclin B1 immunoprecipitates from either control or irradiated samples (data not shown). These data demonstrate that p21/WAF1 Figure 4 Control and irradiated skin samples were incubated with BrdU from either 0 ± 24 h or 24 ± 48 h after irradiation, then stained for BrdU incorporation and the proportion of BrdU positive cells quanti®ed Figure 5 Tissue sections from similar time course to that in Figure 2 were immunostained for PCNA and the proportion of cells with cytoplasmic and/or nuclear staining quanti®ed Figure 6 Tissue extracts from either unirradiated control skin samples (con), irradiated with 250 Jm 72 UVB (UV) or irradiated and addition of 50 mM caeine at 24 h after irradiation (UV+ca.) then harvested at 48 h after irradiation. Samples were immunoblotted for cyclin B1 and PY15 as in Figure 3 . The empty arrowhead indicates a non-speci®c band and the ®lled arrowhead the cyclin B1 band and GADD45 were unlikely to contribute to the G2 arrest observed in the basal layer cells.
Discussion
This is the ®rst detailed analysis of the cell cycle responses of melanocytes and keratinocytes in human skin to UVR. We have observed increased BrdU incorporation during the ®rst 24 h following irradiation, suggesting that UVR is acting as a mitogen, stimulating a rapid round of DNA synthesis. The reduced BrdU labelling from 24 ± 48 h demonstrated that cells did not re-enter S phase during this period.
The relocation of PCNA from the nucleus to the cytoplasm at this time was unexpected, although this has been reported previously in UV-irradiated melanocytes associated with a G2 arrest (Iyengar, 1994) . The relocation to the cytoplasm would act to reinforce a block on S phase entry, suggesting the cells undergo a cell cycle arrest either in G2 phase immediately after the ®rst round of DNA replication, or in the subsequent G1. The elevated levels of cyclin B1, accumulation of inactive phosphotyrosine 15 form of cdc2 complexed with cyclin B1, a marker of G2 arrest (Gabrielli et al., 1997b) , and the lack of mitotic ®gures (unpublished observations), all point to a cell cycle arrest in G2 phase from 24 ± 48 h. The ability of Figure 7 Control (a,g), and UV radiated skin (b ± f,h) were immunostained for (a,b) p16; (c) p16; (d) same section as in (c) doubled-stained for p16 (red) and cyclin B1 (purple/black); (e) BrdU; (f) same section as in (e) doubled-stained for BrdU (red) and p16 (purple/black); p21 (g,h). Panels a,b,e,f,g,h are at a magni®cation of 4006and panels c,d at 10006 caeine to abrogate this G2-like state is further evidence that the growth stimulated cells arrest in G2 phase.
This G2 phase arrest appears similar to the p53-independent G2 arrest following low dose UVR previously described in in vitro cell culture systems, with the accumulation of high levels of Tyr15 phosphorylated, inactive cdc2/cyclin B1 (Gabrielli et al., 1997a) . The lack of p53 involvement in either the UV response or cell cycle arrest characterized here is surprising, considering that earlier studies have demonstrated a p53-dependent G1 arrest in cell lines and primary cultures of epidermal melanocytes and keratinocytes (Medrano et al., 1995; Petrocelli et al., 1996) . The dierences between the observations reported here and the work using cultured primary epidermal cells are likely to be due to a number of factors. The low levels of UVB used in the experiments reported here are not likely to produce DNA strand breaks in the basal and suprabasal layer cells due to the shielding eects of the upper epidermal layers. Although p53 can be activated by a single DNA strand break (Huang et al., 1996) , the lack of any p21/WAF1 or GADD45 induction in the basal layer cells is further evidence of the absence of strand breaks in these cells. The role of p53 in the response to high doses of UVR has been implicated in an apoptotic rather cell cycle response (Ziegler et al., 1994; Wikonkal and Brash, 1999) . The lack of p53 induction in response to low doses of UVR used in the present study may simply re¯ect this, and no apoptosis was detected under the conditions used in the present studies (Pavey et al., 1999) .
Another factor that may contribute to the dierence between UV responses of cultured cell lines and whole skin is the tissue environment. Basal layer cells have low mitotic activity in unirradiated skin, although they are competent to proliferate (indicated by the uniform staining of basal and suprabasal cell nuclei with PCNA), and are readily stimulated to proliferate by UVR. By contrast, in vitro cultured cells are constantly stimulated to proliferate with exogenously supplied growth factors. In vitro culture also fails to account for the eects of the interactions between cells in tissue, e.g. cell ± cell contacts and paracrine interactions. These cultures are also typically homogeneous cell populations, whereas the epidermal layer of the skin is an interdependent mix of predominantly keratinocytes, interspersed with the occasional melanocyte which are connected with up to 36 of these keratinocytes by dendritic projections (Quevedo, 1969) . After UV exposure keratinocytes produce a range of cytokines and growth factors, and these may in¯uence the shortterm cell cycle responses and longer-term growth and melanizing responses of melanocytes (reviewed in Thody and Graham, 1998) . The keratinocyte derived factors, melanotropin and endothelin has been demonstrated to overcome the UVB-induced G1 arrest in cultured melanocytes Tada et al., 1998) . These paracrine interactions, and possibly other cell ± cell interactions, can in¯uence cell responses to UVR, and are poorly mimicked by the tissue culture systems currently used.
Initiation of the G2 phase arrest in the basal layer cells may facilitate more than a protective checkpoint response to cellular damage. Another skin response to UVR is an increase in melanin content to provide a further level of protection against UV-induced DNA damage and possibly oxidative damage (Thody and Graham, 1998) . aMSH expression increases after UVR, and the binding of aMSH and tyrosinase activity are increased in normal G2 phase and G2 phase arrested melanoma cells, these eects co-operate to increase the sensitivity of irradiated cells to aMSH and stimulate melanin synthesis (McLane and Pawelek, 1988; Watters et al., 1998; Chakraborty et al., 1999) . The G2 arrest in the surrounding basal layer keratinocytes may also be a response to increased aMSH binding to these cells (Chakraborty and Pawelek, 1993) and contribute to the increased melanization of the basal layer.
The strong increase in p16 expression in the basal and suprabasal layer cells following exposure to suberythemal doses of UVB previously reported (Pavey et al., 1999) , is tightly correlated with all the markers of cell cycle arrest examined here. The p16 staining cells also stained for BrdU and cyclin B1, and displayed cytoplasmic relocation of PCNA, indicating that they had transited through S phase and were in G2 phase at 24 h after irradiation. These ®ndings point to the cells containing high levels of p16 being arrest in G2 phase, similar to the correlation between elevated p16 and G2 arrest we have reported with in vitro cultured cells (Wang et al., 1996; Milligan et al., 1998) . P16 is also been reported to increase in cells stimulated to re-enter the cell cycle (Tam et al., 1994) . Although the strong p16 expression reported here was found in growth stimulated cells, it is unlikely to be simply a consequence of re-entry into the cell cycle. The small number of BrdU positive cells found in control skin did not have detectable p16 staining, and treatment of skin with retinoic acid which stimulated proliferation in the basal layer compartment, did not increase p16 expression (Pavey and Gabrielli, manuscript in preparation) . The contribution of the elevated levels p16 Figure 8 Sections from a similar time course to that used in Figure 2 was immunostained for p21 and the proportion of p21 positive cells quanti®ed to the G2 phase arrest is still unclear, but we have previously demonstrated in in vitro cultured cells that p16 inhibits the activation of a cdk4/cyclin D activity in late S/early G2 phase that appears to be required for G2 phase progression . Alternatively, the p16 may have a role in establishing a G1 phase arrest subsequent to the G2 arrest (Shapiro et al., 1998) , or may possibly contribute to both.
In summary, we have shown that in response to suberythemal dose of UVR, basal and suprabasal layer cells in human skin arrest in G2 phase, and this is associated with increased levels of p16. De®ning the normal cell cycle checkpoint responses to UVR provides new insights into how loss of these checkpoints may contribute to UVR induced skin cancer. This work also demonstrates that although cultured cells oer an excellent model system for de®ning molecular mechanisms, tissue environment is an important in¯uence on cellular responses. The development of whole organ models such as one reported here will be essential to help de®ne the normal physiological roles of cellular regulators.
Materials and methods

Organ cultures
Organ cultures were established and maintained as previously described (Pavey et al., 1999) . Brie¯y, neonatal foreskins were obtained after circumcision, and cut into two, and irradiated with 250 ± 875 Jm 72 UVB (875 Jm 72 is equivalent to one minimal erythemal dose, 1 MED) or used as a control, maintained in specialized media supplemented with antibiotics and incubated at 378C in a humidi®ed incubator with the epidermis exposed as previously described (Pavey et al., 1999) .
Bromodeoxyuridine labelling
Tissue samples were incubated in base medium supplemented with 25 mM 5-bromo-2'-deoxyuridine (BrdU), with the epidermis submerged enabling maximal absorption and incorporation. BrdU labelling was undertaken 0 ± 24 h incubation, or 24 ± 48 h incubation following irradiation, and harvested at 24 or 48 h as indicated.
Immunohistochemistry
Immunohistochemistry was performed as described previously (21), using a Zymed Histostain-Plus kit (Zymed, CA, USA) with the substrate AEC (Zymed) or Vector NovaRed (Vector laboratories) to produce a red end product for single antigen detection, or a Zymed Histostain-DS kit (Zymed), for detection of two dierent antigens within the same sample (AEC ± red; NBT/BCIP ± black). Antibodies used were as follows: p16 1 : 300 (Wang et al., 1996) , PCNA 1 : 200 (NCL-PCNA, Novocastra), cyclin B1 1 : 4500 , BrdU 1 : 400 (Ab-2, NeoMarkers, LabVision), p21/WAF1 1 : 300 (Calbiochem), phospho-cdc2 (PY15) 1 : 20 (New England Biolabs), and GADD45 1 : 200 (Santa Cruz). Antigen retrieval was performed for p16, PCNA, cyclin B1, BrdU, p21/WAF1 and PY15 as previously described (Pavey et al., 1999) . For BrdU staining of formalin®xed tissues, sections were incubated in 4 M HCl for 30 min at room temperature, followed by digestion with trypsin at 1 mg ml 71 in PBS for 10 min at 378C. The sections were then blocked and stained as for other antigens.
Tissue extracts
Tissue samples were removed from the media and snap frozen and stored at 7808C until analysis. Tissue was cut into small pieces and placed in 1.2 ml extraction buer containing 300 mM NETN/NaCl (300 mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40, and 20 mM Tris, 8 pH) supplemented with 5 mg/ml aprotinin, 5 mg/ml leupeptin, 5 mg/ml pepstatin, 10 mM NaF, 0.1 mM sodium orthovanadate, and 0.5 mM phenylmethylsulphonyl¯uoride. Tissue was homogenized on ice using a Polytron Homogeniser with a 7 mm aggregate (Kinematic AG, Switzerland), using 3 ± 4 pulses at 5000 r.p.m. for a duration of 5 s/pulse. Extracts were then ultracentrifuged in a TL-100 ultracentrifuge (Beckman), at 135 000 g for 1 h at 48C. Samples were equilibrated on the basis of the level of tubulin expression by SDS ± Page and immunoblotting with a tubulin antibody 1 : 500 (Amersham Pharmacia Biotech, Sweden).
Immunoprecipitation and immunoblotting
The tissue extracts were precleared with 50 ml of a 50% suspension of Protein A-Sepharose (CL-4B Amersham Pharmacia Biotech, Sweden) for 1 h, and the cleared extracts were incubated with 0.5 mg of anti-cyclin B1 antibody prebound to 30 ml of a 50% solution of Protein-A-Sepharose overnight at 48C. The supernatant was then removed and precipitates were washed four times with the extraction buer. SDS sample buer was then added to the precipitates and supernatants and boiled for 20 min and 3 min respectively. Immunoprecipitates were resolved on a 10% SDSpolyacrylamide gel, transferred to PVDF membrane (NEN Life Science Products), and immunoblotted for associated proteins using the indicated antibody at 48C overnight. Protein-A conjugated-HRP (ICN), secondary antibody was used for detection using chemiluminescence with a Western blot Chemiluminescence Reagent Plus Kit (NEN Life Science Products).
Evaluation of expression
There were a total of 88 samples collected and analysed, consisting of: (a) 16 unirradiated controls; (b) 16 irradiated with 250 Jm 72 UVB; (c) 16 unirradiated controls and 16 UVB irradiated samples used for BrdU incorporations studies; (d) 12 unirradiated controls and 12 UVB irradiated samples used for preparation of tissue extracts. A time course was undertaken on 16 of the control and 16 of the UV irradiated samples, and were harvested at 0, 8, 16, 24, 48 and 72 h in organ culture for both irradiated and unirradiated control samples. A cell was considered to be immunolabelled and positive for the cell cycle markers used, if there was a visibly detectable signal within the nucleus, cytoplasm, or both nucleus and cytoplasm of a cell. A ®eld on each slide representative of the entire sample was selected and the number of cells expressing the protein of interest were measured and reported as a percentage of the total number of cells counted in each ®eld as previously described (Pavey et al., 1999) . All nucleated cells within the epidermal layers were included in the analyses. From the ®elds analysed, there was an average of 168 cells counted per ®eld.
